Live Breaking News & Updates on Pounce Arterial

Stay updated with breaking news from Pounce arterial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023,. ....

New York , United States , Eden Prairie , Gary Maharaj , Surmodics Inc , Abbott Vascular Inc , Quarter Fiscal , Recent Business , Endovascular Issues , Low Profile , Thrombectomy System , Medical Device , Vitro Diagnostics , Abbott Vascular , Call Today , Private Securities Litigation Reform Act , Endovascular Today , Pounce Arterial , Annual Report , Consolidated Statements , Months Ended December , Stockholder Equity , Cash Equivalents , Device Revenue , Fiscal Year Ending September , Distribution Agreement ,

Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Fina

EDEN PRAIRIE, Minn. (BUSINESS WIRE) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its first quarter ended December 31, 2023, and updated its financial guidance for fiscal year ending Septemb. ....

New York , United States , Eden Prairie , Gary Maharaj , Abbott Vascular Inc , Surmodics Inc , Quarter Fiscal , Recent Business , Endovascular Issues , Low Profile , Thrombectomy System , Medical Device , Vitro Diagnostics , Abbott Vascular , Call Today , Private Securities Litigation Reform Act , Endovascular Today , Pounce Arterial , Annual Report , Consolidated Statements , Months Ended December , Cash Equivalents , Device Revenue ,

Surmodics, Inc. (NASDAQ:SRDX) Q4 2023 Earnings Call Transcript

Operator: Welcome everyone to Surmodics Fourth Quarter and Fiscal Year 2023 Earnings Call. Please note that this call is being webcast. ....

New York , United States , Tim Arens , Gary Maharaj , Performance Coating Services , Surmodics Inc , Call Transcript November , Surmodics Fourth Quarter , Fiscal Year , Investor Relations , Private Securities Litigation Reform Act , Surmodic President , Chief Executive , Medical Device , Performance Coatings , Pounce Arterial Thrombectomy , Vitro Diagnostics , Sublime Radial , Medical Device Performance Coatings , Pounce Venous Thrombectomy System , Pounce Sublime , Chief Financial Officer , Performance Coating , Serene Coating , Veil Drug Coated Balloon , Excluding Surveil ,

Surmodics, Inc. (NASDAQ:SRDX) Q2 2023 Earnings Call Transcript

Operator: Welcome everyone to Surmodics’ Second Quarter and Fiscal Year 2023 Earnings Call. Please note that this call is being webcast. ....

Mike Matson , Gary Maharaj , Tim Arens , Timothy Arens , Surmodics Inc , Peripheral Intervention Community , Call Transcript April , Surmodic Second Quarter , Fiscal Year , Investor Relations , Safe Harbor Provisions , Private Securities Litigation Reform Act , Surmodics President , Chief Executive , Surveil Drug Coated Balloon , Sublime Radial , Pounce Arterial Thrombectomy , Medical Device Coatings , Endovascular Today , Pounce Arterial , Pounce Venous Thrombectomy , Sublime Radial Access , Low Profile , Pounce Excel , Chief Financial Officer , Profitable Industrial Stocks ,

Surmodics, Inc. (SRDX) CEO Gary Maharaj on Q2 2022 Results - Earnings Call Transcript

Surmodics, Inc. (NASDAQ:NASDAQ:SRDX) Q2 2022 Earnings Conference Call April 27, 2022, 08:30 AM ET Company Participants Tim Arens - SVP, Finance & CFO Gary Maharaj - President & CEO. ....

United States , Baton Rouge , South Dakota , City Of , United Kingdom , Charing Cross , David Saxon , Gary Ansel , Jim Sidoti , Mike Petusky , Gary Maharaj , Tim Arens , Company Participants , Surmodics Inc , Physician Steering Committee , Charing Cross International Symposium , Value Analysis Committee , Sidoti Company , Barrington Research , Conference Call April , Street Capital , Surmodics Second Quarter Fiscal , Senior Vice President , Chief Financial , Private Securities Litigation Reform Act , Investor Relations ,